Skip to main content

Drug Interactions between Alka-Seltzer Heartburn ReliefChews and omeprazole

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

No interactions were found between Alka-Seltzer Heartburn ReliefChews and omeprazole. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Alka-Seltzer Heartburn ReliefChews

A total of 222 drugs are known to interact with Alka-Seltzer Heartburn ReliefChews.

  • Alka-seltzer heartburn reliefchews is in the drug class antacids.
  • Alka-seltzer heartburn reliefchews is used to treat the following conditions:


A total of 224 drugs are known to interact with omeprazole.

Drug and food interactions


calcium carbonate food

Applies to: Alka-Seltzer Heartburn ReliefChews (calcium carbonate)

Calcium absorption may be increased by taking it with food. However, foods high in oxalic acid (spinach or rhubarb), or phytic acid (bran and whole grains) may decrease calcium absorption. Calcium may be taken with food to increase absorption. Consider spacing calcium administration for at least 2 hours before or after consuming foods high in oxalic acid or phytic acid. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Report options

QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.